In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam/ aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India

Cefiderocol (FDC), a novel siderophore drug, is active against Gram-negative bacteria producing carbapenemases, including metallo-beta-lactamases. The objective of this study is to compare the in vitro activity of FDC with ceftazidime-avibactam (CZA), CZA/aztreonam (AT) combination, and colistin (CS...

Descripción completa

Detalles Bibliográficos
Autores principales: Borde, Kalyani, Kareem, M. A., Sharma, Ratna Mani, Dass, S. Manick, Ravi, Vedantham, Mathai, Dilip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580817/
https://www.ncbi.nlm.nih.gov/pubmed/37737637
http://dx.doi.org/10.1128/spectrum.00847-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580817/
https://www.ncbi.nlm.nih.gov/pubmed/37737637
http://dx.doi.org/10.1128/spectrum.00847-23

Ejemplares similares